Advice for
healthcare
professionals1,2

  • It is recommended that patients are prescribed two EpiPen Auto-Injectors which they should carry at all times.
  • The physician prescribing an EpiPen Auto-Injector must ensure that the patient understands the indications for use and the correct method of application. Therefore, the physician should discuss the patient information leaflet, the correct handling of the Auto-Injector and the possible symptoms of an anaphylactic shock in detail with the patient.
  • An initial dose should be administered as soon as symptoms of anaphylaxis are recognized.In the absence of clinical improvement or if deterioration occurs, a second injection with an additional EpiPen
    Auto-Injector may be administered 5 - 15 minutes after the first injection.
  • It is strongly advised also to educate the patient’s immediate associates (e.g. parents, caregivers, teachers) for the correct usage of the EpiPen in case support is needed in the emergency situation.

References

  • EpiPen (adrenaline) 300 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics. Available at: www.medicines.ie. Last accessed: 24th October 2025.
  • EpiPen Junior (adrenaline) 150 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics. Available at: www.medicines.ie. Last accessed: 24th October 2025.

The website you are trying to access is designed for healthcare professionals, the content is not designed for the general public.


Are you a healthcare professional registered in Ireland?

YES
NO

EpiPen® (adrenaline) and EpiPen® Junior (adrenaline) Auto-Injectors are indicated in the emergency treatment of severe allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens, as well as idiopathic or exercise induced anaphylaxis.

Product subject to medical prescription which may be renewed (B)

This site is designed for healthcare professionals registered in Ireland, if you are not a healthcare professional registered in Ireland, please
click here to visit our patient website.

For full prescribing information please see:

EpiPen® (adrenaline) 300 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics

EpiPen® Junior (adrenaline) 150 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics

For abbreviated prescribing information (AbPI) please see:

EpiPen 300 micrograms solution for injection in pre-filled pen Abbreviated Prescribing Information (AbPI)

EpiPen Junior 150 micrograms solution for injection in pre-filled pen Abbreviated Prescribing Information (AbPI)

This website is owned and managed by Viatris.

©2025 Viatris. All rights reserved.

Viatris, Newenham Court, Northern Cross, Malahide Road, Dublin 17, Ireland.

Job Code: IE-EPI-2025-00014
Date of preparation: October 2025

Reporting of adverse reactions:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.


Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system HPRA Pharmacovigilance, Website: www.hpra.ie


Adverse reactions/events should also be reported to the marketing authorisation holder at email address: pv.ireland@viatris.com or phone 0044 (0) 800 1218267.

Register for Viatris Connect today ?

Please note that the website contains promotional and non-promotional materials, including educational content and resources to help you and your patients.

REGISTER NOW